Tumor Protein p63/microRNA Network in Epithelial Cancer Cells

Edward A Ratovitski1

  • 1Department of Otolaryngology/Head and Neck Surgery, Head and Neck Cancer Research Division, The Johns Hopkins University School of Medicine, Cancer Research Building II, 1550 Orleans Street, Baltimore, MD 21231, U.S.A.

Current Genomics
|January 8, 2014
PubMed

Insights

Tumor protein 63 (TP63) and microRNAs regulate cancer cell stress responses, impacting chemotherapy effectiveness and chemoresistance in epithelial cancers. This network influences key cellular processes, offering new therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • Non-coding microRNAs regulate cancer cell responses to stress, including apoptosis, cell cycle arrest, and autophagy.
  • Multiple molecular layers, such as epigenetic regulation and RNA processing, are involved in these cellular responses.
  • The interplay between tumor protein (TP)-p53 family members and microRNAs is crucial for cancer cell response to chemotherapy and chemoresistance.

Purpose of the Study:

  • To investigate the role of TP63 in modulating microRNA expression.
  • To elucidate the TP63/microRNA network's involvement in epithelial cancer biology and chemoresistance.
  • To explore potential novel chemotherapeutic strategies based on this network.

Main Methods:

  • Analysis of TP63-modulated microRNAs in various epithelial cancers.
  • Investigation of the TP63/microRNA network's impact on cellular processes like proliferation, differentiation, and metabolism.
  • Examination of the network's role in chemoresistance mechanisms.

Main Results:

  • TP63 modulates numerous microRNAs involved in epithelial cell regulation (proliferation, differentiation, senescence, stemness, EMT).
  • The TP63/microRNA network is implicated in epithelial cancers, including squamous cell carcinoma, ovarian, prostate, gastric, bladder, and breast tumors.
  • This network significantly influences cancer cell chemoresistance.

Conclusions:

  • The TP63/microRNA network is a key player in epithelial cancer development, progression, and chemoresistance.
  • This network regulates critical cellular functions such as cell cycle arrest, apoptosis, autophagy, metabolism, and epigenetic transcriptional regulation.
  • Targeting the TP63/microRNA network presents promising avenues for novel cancer chemotherapeutic interventions.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K